Robert J. D'Amato

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function.

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.

Genetic loci that control vascular endothelial growth factor-induced angiogenesis.

Genetic loci that control the angiogenic response to basic fibroblast growth factor.

Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.

Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.

X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.

Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

The effect of genetic diversity on angiogenesis.

Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.

Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.

A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice.

Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution.

Angiogenesis and antiangiogenic therapy in endometriosis.

Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

The mouse cornea micropocket angiogenesis assay.

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Dendritic cells augment choroidal neovascularization.

Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs.

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.

Genetic loci that control the size of laser-induced choroidal neovascularization.

Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Angiogenesis in wounds treated by microdeformational wound therapy.

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.

A morphometric study of mechanotransductively induced dermal neovascularization.

Forty-year journey of angiogenesis translational research.

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.

The classical pink-eyed dilution mutation affects angiogenic responsiveness.

Common polymorphisms in angiogenesis.

The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.

The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Suppression of autoimmune retinal inflammation by an antiangiogenic drug.

Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal models.

Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.